Journals / Gülhane Tıp Dergisi / 2008 / Cilt: 50 - Sayı: 1

The analysis of N2 positivity in 21 cases with lung cancer not evaluated with mediastinoscopy

Mediyastinoskopi yapılmayan 21 akciğer kanserli olguda N2 pozitifliğinin araştırılması

Pages
9–12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Carrying out the inva- sive and non-invasive staging methods according to an algo- rithm will allow us to evaluate the N2 positivity more cor- rectly and decrease the rate of unnecessary thoracotomies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The analysis of N2 positivity in 21 cases with lung cancer not evaluated with mediastinoscopy The aims of this study were to investigate the rate of N2 positivity in patients treated surgically on the basis of radi- ological staging, to discuss the various aspects of mediasti- nal lymph node staging in the light of literature knowledge and to try to constitute an algorithm.
📊
Key Findings & Data:Twenty one patients with primary lung cancer who were treated surgically assuming N2 negative clinically at our clinic between 2005 and 2006 were reviewed retrospectively with respect to age, gender, methods of diagnosis and staging, clinical stage, pathological stage, histopathological type, surgical treatment performed and the methods of mediastinal lymph node sampling.
💡
Conclusion & Impact:Carrying out the inva- sive and non-invasive staging methods according to an algo- rithm will allow us to evaluate the N2 positivity more cor- rectly and decrease the rate of unnecessary thoracotomies.
🔬Design:Survey & Empirical Study
📍Scope:2005 Verileri
⚙️Variables:Akciğer neoplazmları · Lenf düğümleri · Mediastinoskopi

Abstract

The analysis of N2 positivity in 21 cases with lung cancer not evaluated with mediastinoscopy The aims of this study were to investigate the rate of N2 positivity in patients treated surgically on the basis of radi- ological staging, to discuss the various aspects of mediasti- nal lymph node staging in the light of literature knowledge and to try to constitute an algorithm. Twenty one patients with primary lung cancer who were treated surgically assuming N2 negative clinically at our clinic between 2005 and 2006 were reviewed retrospectively with respect to age, gender, methods of diagnosis and staging, clinical stage, pathological stage, histopathological type, surgical treatment performed and the methods of mediastinal lymph node sampling. Nineteen and 2 of the patients were male and female, respectively, and their mean age was 62.3 (21- 70) years. Histopathological types were adenocarcinoma in 11 cases, squamouse cell carcinoma in 7 cases, adenos- quamose carcinoma in 2 cases and lymphoepithelioma like carcinoma in 1 case. A lobectomy was performed in 15 patients, bilobectomy in 3 patients, pneumonectomy in 1 patient and wedge resection because of low respiratuar capacity in 2 patients. A computed tomography of the chest only was used in 11 patients, whereas both computed tomography of the chest and positron emission tomography were used in the other 10 patients for mediastinal staging. Clinically 10 and 11 of the patients were staged as IA and IB, respectively. In pathologic staging, the N2 positivity was found in 6 patients (29%). Out of these 6 patients, the histopathological type was adenocarcinoma in 5 patients and squamouse cell carcinoma in 1 patient. Positron emis- sion tomography scanning was performed preoperatively to one of 6 patients with N2 positivity and no activity was observed. A correct mediastinal staging should be per- formed before a surgical resection because surgical treat- ment in N2 positive cases not only contributes to survey but also may have adverse effects considering the probable mor- bidities caused by the surgery itself. Carrying out the inva- sive and non-invasive staging methods according to an algo- rithm will allow us to evaluate the N2 positivity more cor- rectly and decrease the rate of unnecessary thoracotomies.

Özet

Bu çalışmadaki amacımız radyolojik evreleme dikkate alınarak cerrahi tedavi uygulanan hastalarda N2 pozitifliği oranını saptamak, literatür bilgileri ışığında mediyastinal lenf nodu evrelemesinin çeşitli yönlerini tartışmak ve bir algoritm ortaya koymaya çalışmaktır. Kliniğimizde 2005 ile 2006 yılları arasında klinik olarak N2 negatif düşünülerek cerrahi tedavi uygulanan primer akciğer kanserli 21 olgu yaş, cinsiyet, tanı ve evreleme yöntemleri, klinik evre, patolojik evre, histopatolojik tip, uygulanan cerrahi tedavi ve mediyastinal lenf nodu örneklemesi yöntemleri açısından retrospektif olarak incelenmiştir. Olguların 19'u erkek 2'si kadın ve yaş ortalaması 62.3 (21-70) yıl olarak saptanmıştır. Histopatolojik tip olarak 11 olguda adenokarsinom, 7 olguda yassı epitel hücreli karsinom, iki olguda adenoskuamöz karsinom ve bir olguda da lenfoepitelyoma benzeri karsinom saptanmıştır. On beş olguya lobektomi, üç olguya bilobektomi, bir olguya pnömonektomi ve iki olguya solunum rezervlerinin kısıtlı olması nedeniyle "wedge" rezeksiyon uygulanmıştır. Mediyastinal evreleme için 11 olguda sadece toraks tomografisi kullanılırken, 10 olguda toraks tomografisi ve pozitron emisyon tomografisi tetkikleri kullanılmıştır. Klinik olarak olguların 10'u IA ve 11'i IB olarak evrelenmiştir. Patolojik evrelemede 6 olguda (%29) N2 pozitifliği saptanmıştır. N2 pozitif saptanan olgulardan 5'inin adenokarsinom ve birinin yassı epitel hücreli karsinom olduğu saptanmıştır. N2 pozitif olgulardan birine preoperatif dönemde pozitron emisyon tomografisi yapılmış ve radyoaktif madde tutulumu saptanmamıştır. Cerrahi rezeksiyon öncesi doğru mediyastinal evreleme yapılmalıdır çünkü bir kaç özel durum dışında N2 pozitif olan olgularda uygulanacak cerrahi tedavi, surviye katkı sağlamayacağı gibi cerrahinin yol açacağı morbiditeler göz önüne alındığında olumsuz etkileri olabilir. Non-invaziv ve invaziv evreleme yöntemlerinin bir algoritm dahilinde uygulanması, N2 pozitifliğini daha doğru değerlendirmemizi sağlayacak ve gereksiz torakotomilerin oranını azaltacaktır.

🔖

Cite This Article

GÖZÜBÜYÜK, A., KAVAKLI, K., ÇAYLAK, H., GÜRKÖK, S., YÜCEL, O., SAPMAZ, E., DAKAK, M., GENÇ, O. (2008). The analysis of N2 positivity in 21 cases with lung cancer not evaluated with mediastinoscopy. Gülhane Tıp Dergisi, Cilt: 50 - Sayı: 1, 9–12. https://ajindex.com/articles/225519

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Goldstraw P, Manam GC, Kaplan D, et al. Surgical man- agement of nonsmall cell lung cancer with ipsilateral mediastinal lymph node metastasis (N2). J Thorac Cardiovasc Surg 1994; 107: 19-27
  2. Shield TW. The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in nonsmall cell lung cancer lung carcinoma of the lung. J Thorac Cardiovasc Surg 1990; 99: 48-53
  3. Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL, Orringer MB. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. Am J Roentgenol 1985; 144: 261-265
  4. Toloza EM, Harpole L, McCrory DC. Noninvasive stag- ing of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123: 137S-146S
  5. Gdeedo A, Van Schil P, Corthouts B, Van Mieghem F, Van Meerbeeck J, Van Marck E. Prospective evaluation of computed tomography and mediastinoscopy in mediasti- nal lymph node staging. Eur Respir J 1997; 10: 1547-1551
  6. Graeter TP, Hellwig D, Hoffmann K, Ukena D, Kirsch CM, Schafers HJ. Mediastinal lymph node staging in sus- pected lung cancer: comparison of positron emission tomography with F-18 fluorodeoxyglucose and medi- astinoscopy. Ann Thorac Surg 2003; 75: 231-235
  7. Halter G, Buck AK, Schirrmeister H, et al. Lymph node staging in lung cancer using [18F]FDG-PET. Thorac Cardiovasc Surg 2004; 52: 96-101
  8. Konishi J, Yamazaki K, Tsukamoto E, et al. Mediastinal lymph node staging by FDG-PET in patients with non- small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 2003; 70: 500-506
  9. Gupta NC, Greaber GM, Bishop HA. Comparative effi- cacy of positron emission tomography with flourode- oxyglucose in evaluation of small (_____1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest 2000; 117: 773-778
  10. Gould MK, Kuschner WG, Rydzak CE, et al. Test perfor- mance of positron emission tomography and computed tomography for mediastinal staging in patients with non- small cell lung cancer: a meta-analysis. Ann Intern Med 2003; 139: 879-892
  11. Langen AJ, Raijmakers P, Riphagen I, Paul MA, Hoekstra OS. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg 2006; 29: 26-29
  12. Watanabe Y, Shimizu J, Tsubota M, Iwa T. Mediastinal spread of metastatic lymph nodes in bronchogenic carci- noma. Mediastinal nodal metastases in lung cancer. Chest 1990; 97: 1059-1065
  13. Vallieres E, Waters PF. Incidence of media